Page 80 - MEMORIA ANUAL 2020

PROGRAMA ESPAÑOL DE TRATAMIENTOS EN HEMATOLOGÍA (PETHEMA)
MEMORIA ANUAL 2020
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
• Evolving treatment patterns and outcomes of 3637 ≥ 60 year-old patients with newly diag- nosed AML reported to the PETHEMA epidemiologic registry.
25th Congress of the European-Hematology-Association (EHA). EHA25 virtual (JUN 10-21).
Acuna-Cruz E, Martínez-Cuadrón D, Serrano J, Gil C, Tormo M, Martínez P, García-Boyero R, C. Be- navente, Rodríguez-Medina C, López-Pavia M, Rodríguez-Macías G, Lavilla E, Amigo M, Herrera P, Bernal T, Bergua J, López-Lorenzo JL, Pérez Simón JA, Colorado M, Sayas MJ, Vidriales B, Pérez- Encinas M, López A, Algarra L, Vives S, Sanz MA, Montesinos P.
• Characteristics and treatment strategies of secondary acute myeloid leukemia patients: data from the PETHEMA AML epidemiologic registry.
25th Congress of the European-Hematology-Association (EHA). EHA25 virtual (JUN 10-21).
Martínez-Cuadrón D, Serrano J, Martínez P, Pérez Simón JA, Gil C, Aguiar E, Bergua J, López-Loren- zo JL, Bernal T, Espadana A, Colorado M, Rodríguez-Medina C, López-Pavia M, Tormo M, Algarra L, Amigo M, Sayas M. J, Labrador J, Rodríguez JI, Benavente C, Costilla L, García-Boyero R, Lavilla E, Vives S, Herrera P, García-Belmonte D, Herráez M, Vasconcelos-Esteves G, Gómez-Roncero MI, Cabello A, Bautista G, Balerdi A, Mariz J, Boluda B, Megías-Vericat JE, Sanz MA, Montesinos P.
• Incidence and outcome of patients with rare acute promyelocytic leukemia variants: the PETHEMA-APL registry experience.
25th Congress of the European-Hematology-Association (EHA). EHA25 virtual (JUN 10-21).
Sobas M, Talarn-Forcadell M, Martínez-Cuadrón D, Escoda Teigell L, García Pérez MJ, Mariz J, Mela-Osorio MJ, Fernández I, Alonso-Domínguez JM, Carnago Navascues J, Rodríguez-Macías G, Amutio Diez ME, Rodríguez-Medina C, Esteve J, Sokoł A, Murciano Carrillo T, Calasanz MJ, Barrios M, Barragán E, Sanz MA, Montesinos P.
• Cost-effectiveness of gemtuzumab ozogamicin in combination with standard of care chemo- therapy for first-line treatment of patients with CD33-positive acute myeloid leukemia in Spain. 25th Congress of the European-Hematology-Association (EHA). EHA25 virtual (JUN 10-21).
Sierra J, Mareque M, Montesinos P, Guinea JM, Font P, Oyáguez I, Brockbank J, Candini D, Llinares J, Soto J, De La Fuente A.
• FLOWCT: a semi-automated workflow for deconvolution of immunophenotypic data and objective reporting on large datasets.
25th Congress of the European-Hematology-Association (EHA). EHA25 virtual (JUN 10-21).
80